Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
Valeria Gaspari, Corrado Zengarini, Sonia Greco, Valeria Vangeli, Antonio Mastroianni
Topics & Concepts
RuxolitinibJanus kinaseCoronavirus disease 2019 (COVID-19)Incidence (geometry)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakSide effect (computer science)Intensive care medicineInternal medicineVirologyComputer scienceProgramming languageMyelofibrosisOutbreakDiseasePhysicsBone marrowOpticsInfectious disease (medical specialty)CytokineMyeloproliferative Neoplasms: Diagnosis and TreatmentAutoimmune and Inflammatory Disorders ResearchDrug-Induced Hepatotoxicity and Protection